Data is not available at this time.
Medical Facilities Corporation operates a network of specialty surgical hospitals and an ambulatory surgery center in the United States, focusing on high-margin outpatient and elective procedures. The company’s facilities provide surgical, imaging, diagnostic, and pain management services, complemented by ancillary offerings like urgent care and occupational health. This positions it within the growing demand for specialized, cost-effective healthcare solutions outside traditional hospital settings. Medical Facilities Corporation differentiates itself through a focus on physician partnerships and efficient, patient-centric care delivery, which enhances revenue stability and operational control. The company operates in a competitive but fragmented industry, where its scale and specialization allow it to capture market share in regional markets. Its ambulatory surgery center further diversifies revenue streams by catering to scheduled outpatient procedures, aligning with broader healthcare trends toward outpatient care. The company’s U.S.-based operations provide exposure to a larger healthcare market while benefiting from a capital-light ownership structure.
In its most recent fiscal year, Medical Facilities Corporation reported revenue of CAD 331.5 million, with net income of CAD 73.5 million, reflecting a robust net margin of approximately 22.2%. The company generated CAD 83.3 million in operating cash flow, underscoring strong cash conversion from operations. Capital expenditures were modest at CAD 7.1 million, indicating efficient reinvestment relative to cash flow generation.
The company’s diluted EPS of CAD 3.02 highlights its earnings power, supported by a capital-efficient model with low leverage. Operating cash flow covers capital expenditures by a wide margin, allowing for consistent profitability without excessive reinvestment needs. The beta of 0.658 suggests lower volatility compared to the broader market, aligning with its stable cash flow profile.
Medical Facilities Corporation maintains a solid balance sheet, with CAD 108.5 million in cash and equivalents against total debt of CAD 73.9 million, indicating a healthy liquidity position. The low debt-to-equity ratio reflects prudent financial management, reducing reliance on external financing. This strength provides flexibility for strategic initiatives or dividend sustainability.
The company has demonstrated steady performance, supported by its focus on high-demand outpatient services. Its dividend of CAD 0.36 per share offers a yield that aligns with its earnings and cash flow stability. Growth prospects are tied to organic expansion and potential acquisitions in the fragmented U.S. specialty healthcare market.
With a market capitalization of approximately CAD 299 million, the company trades at a P/E multiple reflective of its niche positioning and stable cash flows. Investor expectations appear balanced, considering its lower beta and consistent profitability in a defensive sector.
Medical Facilities Corporation benefits from its specialized focus, physician partnerships, and efficient operations, which mitigate risks associated with broader healthcare cost pressures. The outlook remains positive, supported by demographic trends favoring outpatient care and the company’s ability to capitalize on regional demand for high-quality surgical services.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |